Diana Kata
Szeged, CS, Hungary
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 15 publications
Efficacy, Safety, and Cost-Effectiveness of the Infliximab Biosimilar GP-1111 in Patients with Inflammatory Bowel Disease Who Underwent a Nonmedical Switch: A Prospective Cohort Study.
Journal: Biologics : targets & therapy
Published: August 11, 2025
Nimodipine reduces microglial activation in vitro as evidenced by morphological phenotype, phagocytic activity and high-throughput RNA sequencing.
Journal: British journal of pharmacology
Published: November 26, 2024
Bafilomycin 1A Affects p62/SQSTM1 Autophagy Marker Protein Level and Autophagosome Puncta Formation Oppositely under Various Inflammatory Conditions in Cultured Rat Microglial Cells.
Journal: International journal of molecular sciences
Published: July 05, 2024
Outcomes of treatment cessation after switching to subcutaneous vedolizumab treatment in inflammatory bowel diseases.
Journal: Therapeutic advances in gastroenterology
Published: June 26, 2024
Letter: Experience of switching vedolizumab treatment from intravenous to subcutaneous formulation in Hungary.
Journal: Alimentary pharmacology & therapeutics
Published: June 23, 2023
Plasminogen Activator Inhibitor 1 Is a Novel Faecal Biomarker for Monitoring Disease Activity and Therapeutic Response in Inflammatory Bowel Diseases.
Journal: Journal of Crohn's & colitis
Published: May 18, 2023
Immunofluorescent Evidence for Nuclear Localization of Aromatase in Astrocytes in the Rat Central Nervous System.
Journal: International journal of molecular sciences
Published: July 06, 2022
Rationally designed foldameric adjuvants enhance antibiotic efficacy via promoting membrane hyperpolarization.
Journal: Molecular systems design & engineering
Published: August 17, 2021
Advances in the optimization of therapeutic drug monitoring using serum, tissue and faecal anti-tumour necrosis factor concentration in patients with inflammatory bowel disease treated with TNF-α antagonists.
Journal: Expert opinion on biological therapy
Published: February 15, 2021
Sensitivity of Rodent Microglia to Kynurenines in Models of Epilepsy and Inflammation In Vivo and In Vitro: Microglia Activation is Inhibited by Kynurenic Acid and the Synthetic Analogue SZR104.
Journal: International journal of molecular sciences
Published: November 09, 2020
Rational design of balanced dual-targeting antibiotics with limited resistance.
Journal: PLoS biology
Published: February 28, 2020
Potent Chimeric Antimicrobial Derivatives of the Medicago truncatula NCR247 Symbiotic Peptide.
Journal: Frontiers in microbiology
Published: November 15, 2019
Last Updated: 09/26/2026